Literature DB >> 2172234

Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity.

R N Kolesnick1, M R Hemer.   

Abstract

This laboratory first provided evidence for a potential signal transduction pathway involving sphingomyelin and its derivatives (Kolesnick, R.N., and Clegg, S. (1988) J. Biol. Chem. 263, 6534-6537). Recently, this laboratory demonstrated the existence of the novel sphingolipid ceramide 1-phosphate in human leukemia (HL-60) cells. Ceramide 1-phosphate was synthesized from ceramide derived from sphingomyelin but not glycosphingolipids. This suggested that a specific pathway extended from sphingomyelin to ceramide 1-phosphate. The present studies provide additional support for this notion by demonstrating the existence of a ceramide kinase activity distinct from diacylglycerol (DG) kinase in HL-60 cells. Microsomal membranes contained a kinase activity that phosphorylated ceramide but not 1,2-DG in the presence of physiologic and higher Ca2+ concentrations (60 nM-3 mM). Kinetic analyses demonstrated an apparent Vmax for ceramide and ATP of 70 pmol.min-1.mg protein-1; apparent Km values were 45 and 25 microM, respectively. The pH optimum was within the physiologic range (pH 6-8). Magnesium but not other divalent cations (Mn2+, Ba2+, Cd2+, Zn2+) also stimulated ceramide phosphorylation. Magnesium also induced 1,2-DG phosphorylation. Since DG kinase is a Mg2(+)-stimulable enzyme that may utilize ceramide as substrate, additional studies separated calcium-dependent ceramide kinase from DG kinase activity. 1,2-DGs competitively inhibited magnesium- but not calcium-dependent ceramide phosphorylation. Hence, calcium-dependent ceramide kinase activity neither utilized DG as substrate nor was inhibited by DG. These activities were physically separable. Both activities were solubilized by n-octyl-beta-D-glucopyranoside and stabilized by glycerol. Ceramide kinase activity bound weakly to a DEAE-cellulose anion exchange column and eluted with 4-fold purification as a single peak of activity in the flow-through and 0.05 M NaCl elutions. In contrast, the majority of DG kinase activity bound more tightly and was recovered as a broad peak in the 0.2-0.35 M NaCl elutions. These studies demonstrate the existence of a ceramide kinase activity in HL-60 cells which is functionally and physically separable from DG kinase. These studies provide further support for the notion of a specific pathway from sphingomyelin to ceramide 1-phosphate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172234

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Sphingolipid metabolism in the regulation of bioactive molecules.

Authors:  C Luberto; Y A Hannun
Journal:  Lipids       Date:  1999       Impact factor: 1.880

2.  A critical beta6-beta7 loop in the pleckstrin homology domain of ceramide kinase.

Authors:  Philipp Rovina; Markus Jaritz; Siegfried Höfinger; Christine Graf; Piroska Dévay; Andreas Billich; Thomas Baumruker; Frédéric Bornancin
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

3.  UV irradiation-induced apoptosis leads to activation of a 36-kDa myelin basic protein kinase in HL-60 cells.

Authors:  M L Lu; M Sato; B Cao; J P Richie
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

4.  Stimulation of DNA synthesis by natural ceramide 1-phosphate.

Authors:  A Gomez-Muñoz; L M Frago; L Alvarez; I Varela-Nieto
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

5.  A fluorescent plate reader assay for ceramide kinase.

Authors:  Anthony S Don; Hugh Rosen
Journal:  Anal Biochem       Date:  2007-12-25       Impact factor: 3.365

Review 6.  Signal transduction of stress via ceramide.

Authors:  S Mathias; L A Peña; R N Kolesnick
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

7.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

Review 8.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

9.  Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

Authors:  Masahito Kawabori; Rachid Kacimi; Joel S Karliner; Midori A Yenari
Journal:  World J Cardiol       Date:  2013-04-26

10.  Ovalbumin-induced plasma interleukin-4 levels are reduced in ceramide kinase-deficient DO11.10 RAG1-/- mice.

Authors:  Satoru Niwa; Nicole Urtz; Thomas Baumruker; Andreas Billich; Frédéric Bornancin
Journal:  Lipids Health Dis       Date:  2010-01-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.